ArticleEmerging infectious diseases2013
Think fungus–prevention and control of fungal infections.
Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Article
- Awareness and perception of invasive fungal diseases among the Nigerian population.Journal of public health in Africa · 2025Article
- Higher white-nose syndrome fungal isolate yields from UV-guided wing biopsies compared with skin swabs and optimal culture media.BMC veterinary research · 2023Article
- Characterization of the Urinary Metagenome and Virome in Healthy Children.Biomedicines · 2022Article
- Application of Non-Thermal Plasma to Fungal Resources.Journal of fungi (Basel, Switzerland) · 2022Review
- Identification of Dual-Target Compounds with Antifungal and Anti-NLRP3 Inflammasome Activity.ACS infectious diseases · 2021Article
- Tracing the origin of the crayfish plague pathogen, Aphanomyces astaci, to the Southeastern United States.Scientific reports · 2021Article
- Cross-Disciplinary Genomics Approaches to Studying Emerging Fungal Infections.Life (Basel, Switzerland) · 2020Review
- NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis.PLoS pathogens · 2020Article
- Diagnosing Emerging Fungal Threats: A One Health Perspective.Frontiers in genetics · 2018Article
- Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks.The Lancet. Infectious diseases · 2017Review
- The mycobiome of the human urinary tract: potential roles for fungi in urology.Annals of translational medicine · 2017Review
- Discovery and Characterization of a Peptoid with Antifungal Activity againstACS medicinal chemistry letters · 2016Article
- Re-estimation of the burden of serious fungal diseases in Uganda.Therapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.